Abstract. The sensation of pain plays a critical role as an alert and as a protection system against tissue damage from mechanical, chemical, and thermal stimuli. Despite the protective role of pain, the severity of pain sensation is markedly attenuated by the endogenous pain inhibitory systems that predominantly originate at the brain stem. Both behavioral and in vivo extracellular recording studies have sought the loci producing analgesia and clarification of the anti-nociceptive actions. Among those loci, the main descending systems to the spinal dorsal horn are noradrenergic and serotonergic. Although, in vivo studies have provided basic knowledge of these systems, the precise synaptic mechanisms underlying the analgesic actions have not yet been elucidated until recently. The newly developed in vitro slice and in vivo patchclamp recordings have disclosed the synaptic mechanisms of the noradrenergic and serotonergic effects at the level of spinal dorsal horn. This paper reviews the anti-nociceptive action of these systems, while particularly focusing on the electrophysiological aspects of the systems at the single neuron level in the spinal dorsal horn as well as their origins and responsible receptor subtypes.
Introduction
The sensation of pain is known to be modified by endogenous pain inhibitory systems, predominantly through the descending noradrenaline (NA), serotonin (5-HT) (Fig. 1) , and endogenous opioids such as β-endorphin and dynorphin. The activation of the descending systems markedly modifies not only the release of glutamate from the primary afferent or interneurons, but also the release of GABA and glycine. In addition, the output of nociceptive information to the higher pain center from projection neurons is also significantly altered. As a consequence, the severity of pain perception is drastically reduced. From the examinations using brain stem slice preparations, neurons in the NA-and 5-HT-containing nuclei have been shown to tonically active (1 -3) , so the release of glutamate, and GABA and glycine as well as the excitability of the dorsal horn neurons might thus be dynamically controlled. The descending pain inhibitory systems could be temporarily accelerated under certain contingencies. As one wellknown example, the majority of soldiers do not complain of severe pain even after they are wounded severely on the combat field. However, after being treated, the soldiers then begin to complain about pain. This temporal ignorance of pain and fear may thus help them remain conscious, enabling them to make appropriate judgments regarding how to act under extreme situations. Many behavioral and in vivo studies have sought to identify the region that produces such analgesic effects (see ref. 4) . Several loci are known to produce the anti-nociceptive effects on pain transmission, including the cerebral cortex (anterior cingulate, frontal, and parietal lobes); hypothalamus; periaquaductal grey matter (PAG); parabrachial nucleus; nucleus tractus solitarius; RVM (rostral ventromedial medulla, including raphe nuclei); and noradrenergic A5, A6 (locus coeruleus), A7 (subcoeruleus). Among those nuclei, the A5, locus coeruleus, and subcoeruleus (4 -7) as well as RVM (8 -10) systems descend their axons to the spinal cord through the dorsolateral funiculus and their pain inhibitory mechanisms have been extensively investigated using in vivo extracellular recordings and behavioral examinations (11 -16) . Although the nociceptive sensation is modified at the supra-spinal levels, such as parabrachial and PAG (17 -19) , the descending inhibitory systems to the spinal cord are considered to play a critical role in selective modulations of the pain information at the level of spinal cord. This assumption is derived from the fact that the noxious and non-noxious sensations are carried by specific afferent fibers to the different laminae, superficial and deep dorsal horn (20, 21) . It is, therefore, reasonable to assume that the selective modification of noxious inputs without affecting other modalities could be exerted more easily at the spinal level. Several accumulated lines of evidence show that the substantia gelatinosa (SG) neurons of the dorsal horn (lamina II of Rexed) likely play an important role in the modulation of nociceptive transmission from the peripheral to the CNS (20 -25, 27 -30) . Fine myelinated Aδ and unmyelinated C primary afferent fibers, many of which innervate nociceptors, tend to terminate preferentially on the neurons of the superficial dorsal horn, particularly the SG neurons (21 -29) . Intracellular recording studies of the SG neurons have also revealed that the stimulation of primary afferent evokes monosynaptic fast excitatory postsynaptic potentials (EPSPs) and inhibitory postsynaptic potentials (IPSPs) in the majority of SG neurons (30, 31) . In addition, in vivo patch-clamp recording studies have shown that the majority of SG neurons are excited by noxious stimuli (21, 22) . Together with these data, the SG is considered to be essential for the noxious transmission in the spinal dorsal horn. The majority of such investigations have focused on the SG to resolve how noxious and nonnoxious information is modified by the various inputs. In this article, the inhibition of pain transmission revealed by the descending systems is reviewed, particularly focusing on the mechanisms how NA and 5-HT modify the synaptic transmission at the synapses between the dorsal horn neurons and the primary afferent fibers as evaluated by in vitro and in vivo studies.
A. Noradrenergic system
Origin of noradrenergic systems
NA-containing nuclei are divided into A1 to A7 located widely from pons to midbrain, in which a substantial number of neurons in A5, A6 (locus coeruleus), and A7 (subcoeruleus) extend their axon down to the spinal cord through the dorsolateral funiculus (4 -7). NA-containing terminals are distributed in all laminae of the dorsal horn and establish axo-somatic, axodendritic, and axo-axonic synapses (32, 33) . Although NA-containing terminals tend to be concentrated in the superficial dorsal horn, in particular lamina I and the outer layer of lamina II, more dense terminals are found in the intermedialateral (IML) nucleus (a pool of sympathetic preganglionic neurons) and the ventral horn. Axo-axonic synapses in the dorsal horn are predominant with terminals of interneurons; primary afferent terminals also receive inputs from the noradrenergic system (33 -35) . Although the origin of NA is supraspinal, a few spinal neurons, mostly near the central canal, also possess NA (4). As mentioned below, NA produces a direct inhibition of interneurons such as SG neurons (36, 37) , and it is also known that a substantial number of NA terminals make synaptic contacts with projection neurons that extend their axons to the thalamus, indicating the direct control of the output of ascending projection neurons (38) as well as the modification of sensory transmission among interneurons.
Multiple subtypes of adrenergic receptors distributed in the spinal dorsal horn
Major adrenergic receptors are divided into three major subtypes: α 1 , α 2 , and β adrenoceptors. The α 1 receptor has been cloned and subclassified further into α 1A , α 1B , and α 1D ; and these subclasses are coupled to Gq/ 11. The activation of these receptors causes Ca 2+ channel opening to increase transmitter release and activation of phospholipase C (PLC). α 1A receptors are diffusely expressed at higher densities throughout the spinal cord, while α 1B receptors are at intermediate density, and α 1D receptors are scarce (39) . mRNA studies have demonstrated the presence of α 1A , α 1B , and α 1D in the dorsal root ganglion (DRG) (40) . α 1A -receptor mRNA is the most abundant in the spinal dorsal horn. α 2 -receptors are also subclassified into α 2A , α 2B , and α 2C . These receptor subclasses couple to Gi / o and the activation of the receptors causes an opening of the K + channels and a depression of Ca 2+ conductance, resulting in either a membrane hyperpolarization or a decrease in transmitter releases. As a result, α 1 adrenoceptor has an excitatory effect, while α 2 has an inhibitory effect on the sensory transmission. However, it should be noted that the inhibition of inhibitory interneurons simply results in an excitation of transmission. This kind of excitation, so called dis-inhibition, has been reported in PAG in which the activation of opioid receptors endowed on the GABAergic interneurons causes the activation of the descending modulatory systems (41, 42) .
Morphological studies have demonstrated that α 2A receptors are densely expressed in the spinal cord, with higher density in the superficial dorsal horn as well as deeper laminae (43, 44) . Among those receptor subtypes, the α 2A receptor is the most abundant of all other subtypes. SG neurons are endowed with prominent α 2A receptors.
At least 3 adrenergic β receptor subtypes, β 1 , β 2 , and β 3 , have been identified. The existence of β 4 is also suggested but it has not yet been cloned. These NA β subtypes are known to play an excitatory role in the synaptic transmission. However, no clear electrophysiological evidence supporting the involvement of β receptor in the spinal dorsal horn has been reported (36) . The inhibitory actions of NA on the synapses between the primary afferents and dorsal horn neurons have been investigated in the DRG neurons, demonstrating a depression of the Ca 2+ current by the activation of α 2 receptors. These observations can be extrapolated to the primary afferent terminals where the activation of α 2 receptors reduces the glutamate release (45) , causing a decrease in the nociceptive inputs to the dorsal horn neurons (36) . This presynaptic action of NA is further confirmed in the spinal cord, while observing a presynaptic depression of the dorsal root evoked EPSCs in spinal cord slice preparations (see below) (37, 45) . Recent anatomical studies have shown α 2C -adrenergic receptors to be localized on the axon terminals of excitatory interneurons in the superficial dorsal horn that come in contact with spino-medullary projection neurons, possibly contributing to noradrenergic antinociception (44).
Behavioral study
Adrenaline is widely used clinically for spinal anesthesia with local anesthetics with an expectation of a reduction in the clearance of local anesthetics from the subarachnoid space by the constriction of blood vessels (46, 47) . However, adrenaline produces analgesia when administered intrathecally in the absence of local anesthetics (48, 49) ; in fact, they do not significantly alter the clearance of local anesthetics from the subarachnoid space (50, 51) In addition, clonidine, an α 2 agonist without vasoconstrictive effects, prolongs the duration of analgesia (52) . It is therefore likely that the anti-nociceptive actions of intrathecal adrenaline are due to the direct action within the spinal dorsal horn, possibly mimicking the action of the descending noradrenergic pathways.
There is accumulating evidence supporting the idea that the activation of α 2 -adrenoceptor produces a profound analgesic action in normal and chronic pain model animals (53, 54) . Behavioral studies have shown that α2 adrenoceptors mediate spinal analgesia and adrenergic-opioid synergy, which may be useful in clinical pain management (55, 56) . This α 2 -adrenoceptor mediated antinociceptive action is reported to more potent under such pathological conditions as inflammation (56). α 2 -Adrenoceptor agonists are also clinically used for patients suffering from various types of pathological chronic pain, including neuropathic pain.
Electrophysiological study 1) In vitro study
Postsynaptic actions of NA: Although there is accumulating evidence indicating an antinociceptive action of NA at the spinal cord level, the cellular mechanisms at the single cell synapses have long been unknown because of a lack of appropriate methods for addressing the mechanisms of NA actions. In the early 1980's, spinal cord slice preparations from new born and adult animals were established (57 -60) . Since then, the preparations and recording methods have rapidly improved, including the development of a slice with an attached dorsal root making it possible to analyze synaptic responses in dorsal horn neurons by stimulating the identified dorsal root (61) and a slice patch-clamp recording technique (62) . These newly developed techniques thus enable us to analyze a mechanism of NA action at the synaptic level in the spinal cord. The NA action at the single cell synaptic level was reported for the first time in 1984 (60), using intracellular recordings from SG neurons of rat spinal cord slices. Since α 2 receptors are concentrated in the SG, the bath-applied NA produces membrane hyperpolarization by opening K + channels through the activation of α 2 receptors. This hyperpolarizing action shows no significant desensitization (60) . This un-desensitizing response seems to be appropriate for the precise and circumscribable control of nociception. The hyperpolarization in more than 80% of SG neurons by NA (60) may account for the inhibition of the pain behavior, but it is also possible that NA affects the transmitter release in the SG (Fig. 2) .
Presynaptic actions of NA: To address whether spinally administered NA acts presynaptically to alter the excitatory and inhibitory transmitter release and, if so, to identify which receptor subtype is involved, a blind patch-clamp technique to study the action of NA on miniature excitatory and inhibitory postsynaptic currents (mEPSCs and mIPSCs, respectively) in SG neurons from adult rat spinal cord slices was made (45, 63, 64) . In the majority of SG neurons, NA dosedependently increased the frequency of GABAergic and glycinergic mIPSCs, while mEPSCs are not significantly altered in the presence of tetrodotoxin (TTX). This enhancement of mIPSCs is mimicked by an α 1 receptor agonist phenylephrine, and inhibited by α 1 receptor antagonists, prazosin and 2-(2,6-dimethoxyphenoxyethyl) amino-methyl-1,4-benzodioxane. Prazosin is now known to be a potent antagonist for α 2B and α 2C receptors. However, α 2B and α 2C are not responsible for the enhancement, since the α 2 agonist clonidine exerts no significant effect. These results indicate that NA enhances inhibitory transmitter release on the SG through the activation of presynaptic α 1 receptors, thus providing a mechanism underlying the clinical use of α 1 agonists with local anesthetics in spinal anesthesia. Baba et al. (64) further addressed the action of NA on the somatodendritic sites or the terminals of inhibitory interneurons, in particular GABAergic ones. NA causes an increase in not only the frequency but also the amplitude of GABAergic IPSCs. This enhancement of the amplitude is blocked by TTX, indicating that NA initiates the action potentials in the somatodendritic trees of interneurons, resulting in a marked increase of the GABA release onto the recorded neurons. As a result, NA acts on both presynaptic terminals and somatodendritic trees of GABAergic and possibly glycinergic interneurons. However, the membrane depolarization in SG by NA are observed in only a few neurons (60) , suggesting that the GABAergic neurons excited by NA seem to be located outside of SG. Lamina III has also been shown to contain inhibitory neurons immunohistochemically. The direct membrane depolarization observed in a small population of SG neurons is due to a decrease of K + conductance (60). The depolarized neurons seem to be inhibitory since spontaneous IPSPs (or IPSCs) are recorded in the majority of SG neurons, while an increase of EPSPs (or EPSCs) are never observed. Nevertheless, the possibility that excitatory interneurons activated by NA terminate on neurons located at some site other than SG still cannot be ruled out. Since both frequency and amplitude of IPSPs are enhanced by NA, not only the presynaptic terminals but also the soma-dendritic membrane is endowed with the α 1 adrenoceptors, producing neuron firing (63, 64) . NA exerts its antinociceptive actions not only by direct membrane hyperpolarization and enhancement of inhibitory transmitter release, but also reduce the excitatory transmitter release. This presynaptic actions of NA are tested in SG that receive inputs predominantly from Aδ and C afferent fibers, which is known to carry the nociceptive information. Kawasaki et al. (45) examined the presynaptic action of NA on the synaptic transmission of SG neurons with primary afferents using spinal cord slice with an attached dorsal root. The stimulation of the Aδ and C afferent fibers elicits monosynaptic and / or polysynaptic EPSCs. All EPSCs are suppressed by an AMPA-receptor antagonist (65) . Both Aδ and C afferent-evoked EPSCs are reversibly inhibited by NA by 20% -60% without affecting the mEPSCs. Interestingly, the Aδ afferent-evoked EPSCs are more sensitive to NA than the C-afferent-evoked one (45) . Aδ afferents are believed to convey fast and confined pain; thus, NA is presumed to depress more effectively the fast pain than slow long lasting pain. This notion, however, has not yet been confirmed behaviorally. The presynaptic inhibition of transmitter release is mimicked by the α 2 agonist clonidine and its effect is blocked by yohimbine (45) . Although a further classification of the α 2 subtypes has not been addressed electrophysiologically, a release study suggests the involvement of an α 2C subtype, while a knockout study suggests α 2A involvement (66) . Therefore, a more rigorous clarification is clearly required. The administration of β agonists and antagonists are without effects on EPSCs in amplitude and frequency.
Unexpectedly, mEPSCs are not significantly affected by NA, even though NA presynaptically inhibits the evoked EPSCs (45) . This discrepancy may be due to the fact that the SG neurons receive synaptic inputs not only from primary afferents but also more inputs from interneurons. Assuming that the mEPSCs are predominantly from interneurons and those neurons have no α 2 receptors, it might be reasonable to explain why no significant change in the frequency of mEPSCs is observed. Alternatively, NA has an effect on the action potential-induced transmitter release but not on the miniature transmitter release system (Fig. 2) .
2) In vivo patch-clamp study
In slice examinations, it is possible to analyze the action of NA on the synaptic responses evoked by the identified dorsal root. It is, however, impossible to know what kind of sensory information is modified by NA. Furthermore, it is also unclear whether NA acts on the receptors located on the distal dendrites or the proximal dendrites, since the distal dendrites are presumably cut in slice preparations. It is, therefore, conceivable that the action of NA in the spinal cord slice experiments differ in some points from those of NA when using in vivo preparations. In order to evaluate the physiological significance of the neuromodulators on the synaptic responses evoked by different modalities, an in vivo patch-clamp recording technique has been developed (21 -24, 37) that is able to evaluate how sensory inputs are modified by NA at the spinal cord (37). In the current-clamp mode, pinch stimuli applied to the ipsilateral hindlimb elicit a barrage of EPSPs, some of which initiate the action potentials. The perfusion of NA onto the surface of the spinal cord hyperpolarizes the membrane while also suppressing the action potentials. In the voltage clamp mode, the application of NA produces an outward current that is blocked by Cs + and GDP-β-S added to the pipette solution and reduces the amplitude of EPSCs evoked by noxious stimuli. Even after the blockade of the postsynaptic actions of NA by the injection of Cs 2+ and GDP-β-S, a reduction of the evoked and spontaneous EPSCs of the SG neurons are still observed, suggesting both preand postsynaptic actions of NA. The outward current was mimicked by an α 2 -adrenoceptor agonist, clonidine, and suppressed by an α 2 -aferenoceptor antagonist, yohimbine, but not by α 1 -and β-antagonists. These findings suggest that NA acts at presynaptic sites to reduce noxious stimuli-induced EPSCs and acts on postsynaptic SG neurons to produce an outward current by the G-protein-mediated activation of K + channels through α 2 -adrenoceptors, thereby producing an antinociceptive effect.
Using in vivo patch-clamp recordings, Sonohata et al. examined the effect of exogenously applied NA onto the surface of the spinal cord (37) . It is, therefore, impossible to elucidate how endogenously released NA acts on the synaptic transmission in the spinal cord. Further clarification should be made by stimulating a descending NA-containing nucleus such as the locus coeruleus. Furthermore, whether the actions of NA are direct on recorded neurons or occur through the general circulation should be investigated. Sonohata et al. proposed a direct action because of the rapid onset of NA action. This evidence supports the notion that this method is feasible for evaluating the effect of chemicals under in vivo conditions. However, the exact site of the actions of chemicals cannot be tested when a drug is applied to the neurons located at the deeper laminae. Furthermore, a higher concentration and long time application are required to obtain effects of chemicals. This may be due to a diffusion or rapid elimination of the chemicals during diffusion to the deeper laminae.
B. Serotonergic system 1. The origin of the serotonergic system
Similar to a noradrenergic system, the descending serotonin containing fibers arise from the nucleus located within the RVM (38, 67 -69) . In the RVM, the nucleus raphe magnus (NRM) is the main source of serotonergic fibers in the spinal cord. Other serotonergic nuclei, raphe pallidus (RP) and raphe obscurus (RO), are also within the vicinity of RVM. However, the contribution of the latter two nuclei is thought to be small. Like the noradrenergic system, the serotonergic fibers also descend to the spinal cord through the dorsolateral funiculus and bifurcate their axon collaterals to innervate dorsal horn neurons, in particular lamina I and IIo, central canal, IML, and ventral horn (38, 67) . Nonserotonergic neurons are also known to descend to the spinal cord from the RVM, which contains GABA and glycine (69) , and their functions have been recently clarified by an in vivo study (ref. 24 , see below).
Although the supraspinal nuclei are the main sources of 5-HT to the spinal cord, a few serotonergic neurons have been reported to be located around the central canal and dorsal horn. Furthermore, a small proportion of afferent fibers have been reported to contain 5-HT, as revealed by autoradiography and immunochemistry. However, the almost complete elimination of 5-HT immunoreactivity in the spinal cord after spinalization suggests a supraspinal origin of 5-HT. The termination of serotonergic fibers is most abundant in the superficial dorsal horn (lamina I and II) and a less dense termination is also seen throughout the spinal cord. Because the terminals of the descending serotonergic fibers form varicosities, the release of 5-HT would induce volume transmission, thereby widely affecting the vicinity of the release sites. However, other reports have demonstrated a conventional synaptic contact that occurs in axoaxonic, axo-dendritic, and axo-somatic manners. In slice experiments containing RVM, some raphe neurons have been shown to exhibit spontaneous firing even in a slice condition, suggesting that 5-HT or other transmitters, such as GABA or glycine is released tonically onto the dorsal horn neurons (2) . The same spontaneous activity is also observed in locus coeruleus in slices (1, 70) . However, no significant change in the spontaneous EPSCs in SG neurons has been observed during the administration of α 2 receptor antagonist in in vivo experiments (37) . As a result, the tonic contribution of serotonergic and noradrenergic systems on the sensory transmission in the spinal dorsal horn is still uncertain.
The distribution of serotonergic receptor subtypes in the spinal dorsal horn
5-HT receptors have been classified into 14 subtypes (38, 68, 71) and some subclasses are expressed within the spinal cord. Autoradiographic studies show that among these 14 subtypes, the 5-HT 1A , 5-HT 1B , 5-HT 1D , and 5-HT 3 binding sites are abundant in the spinal level. In particular, the binding sites for 8-OH-DPAT, an agonist specific to 5-HT 1A and 5-HT 7 receptors (38, 71) , are localized in the superficial dorsal horn (laminae I and II) (72) . Furthermore, 8-OH-DPAT applied to the spinal cord is known to modulate the nociceptive transmission (73, 74) . 5-HT 1A receptors are densely expressed in superficial layers and its activation causes an opening of K + and a closing of Ca 2+ channels conductance through coupling negatively to adenylate cyclase. Therefore, the activation of this receptor could produce an inhibitory effect on the sensory transmission. The expression of 5-HT 1A receptors on primary afferent fibers has not yet been confirmed. As mentioned below, a 5-HT 1A -receptor agonist, 8-OH-DPAT markedly reduces the release of glutamate from the primary afferents, particularly C afferents. However, this inhibitory action is not blocked by a 5-HT 1A -receptor antagonist, WAY100635 (74) . Among the other 5-HT 1 receptor subtypes, 5-HT 1B and 5-HT 1D receptors are also found throughout the dorsal horn, particularly in the superficial dorsal horn (see review by Millan, ref. 38) . The subpopulation of primary afferent fibers also expresses those receptors. The activation of those receptors expressed on the dorsal horn neurons and primary afferent fibers is reported to produce an antinociceptive effect.
The 5-HT 3 receptor is a ligand-gated, cation permeable ion channel, which is found in the superficial dorsal horn. A marked reduction of the receptors following the elimination of nocisensitive primary afferent fibers indicates the expression of receptors on the central terminals of primary afferent fibers (75, 76) .
Behavioral study
The behavioral studies by stimulation of RVM or injection of 5-HT-receptor agonist or antagonists into the spinal cord have shown both inhibitory and facilitatory effects on the nociceptive behaviors. The application of 5-HT iontophoretically to the spinal dorsal horn generally inhibits nociceptive responses (11), but excitatory effects have also been reported less frequently (77) . Since there are many inhibitory interneurons in the dorsal horn, the excitation produced by 5-HT on those inhibitory neurons may cause the dis-inhibition on the sensory transmission (78) . The stimulation of the raphe magnus causes a inhibition of nociceptive dorsal horn neurons that seems to be mediated by the activation of the descending 5-HT systems since pretreatment of PCPA reduces the effect of raphe stimulation (79, 80) As described above, 5-HT 3 receptors are expressed on small primary afferent fibers and the activation of these receptors may cause the release of glutamate onto the dorsal horn neurons. It is not known whether the interneurons that are activated by released glutamate are excitatory or inhibitory interneurons.
Electrophysiological study 1) In vitro study
Postsynaptic actions: To test the postsynaptic actions of serotonin on the membrane potential or current, whole cell patch-clamp recordings have been made from slice preparations of newborn or adult rats spinal cord (74, 81 -84) . The postsynaptic actions of serotonin are heterogeneous, exhibiting both hyperpolarization (outward current) and depolarization (inward current), differing from neuron to neuron (74, 81, 82) . Some neurons show both hyperpolarizations usually preceding depolarization. The dual actions of serotonin appear to be due to a selective activation of distinct receptors (74) . Among the known 5-HT receptors, 5-HT 1A is dominant in the dorsal horn. The administration of 5-HT causes hyperpolarization (outward current) in about 50% of SG neurons; this inhibitory effects is mimicked by the 5-HT 1A agonist 8-OH-DPAT and blocked by the 5-HT 1A antagonist WAY100635 (82) . These results are consistent with the previous data (83) . In contrast, the membrane depolarization (inward current) are observed in a small population of SG neurons, so a receptor responsible for the depolarization has not yet been identified. The slice examinations suggest that the membrane depolarization is antagonized by a 5-HT 3 -receptor antagonist (Abe, unpublished data), while the involvement of 5-HT 2 receptors has also been proposed (84) . The primary afferents are known to express 5-HT 3 receptors, which are non-selective cationic channels. The activation of the 5-HT 3 receptors produces a rapid depolarization in DRG neurons by increasing the conductance to Na + , K + , and Ca 2+ . The activation of 5-HT 3 receptors is, therefore, expected to increase the transmitter release from the primary afferent terminals into the spinal cord (Fig. 3) .
Presynaptic actions: The presynaptic actions of 5-HT have been examined in the SG neurons of the spinal cord slice preparations of adult rats (74) and newborn rats (84) . Bath-applied 5-HT initially decreases the mEPSCs, subsequently increasing the frequency of mEPSCs in the presence of TTX in the subpopulation of SG neurons (74, 84) . 8-OH-DPAT, an agonist of 5-HT 1A and 5-HT 7 receptors, mimics the decrease in the mEPSCs frequency through the presynaptic mechanism. In contrast, the receptor responsible for the increment of mEPSCs by 5-HT has not yet been clarified, because of a lack of selective agonists and antagonists. The presynaptic actions of 5-HT have also been evaluated on the primary afferent-evoked EPSCs using slices with attached dorsal root preparations (74) . The stimulation of the dorsal root elicits the Aδ and / or C afferent evoked monosynaptic EPSCs. Both EPSCs are reversibly depressed by 5-HT when the postsynaptic actions are blocked by the injection of K + channel blocker, cesium and TEA, which completely suppresses the 5-HTmediated postsynaptic actions, indicating the presynaptic site of action. The depression of C-afferentevoked EPSCs is mimicked by 8-OH-DPAT, while the depression of Aδ afferent-evoked EPSCs is not mimicked. Nevertheless, the depressive action of 8-OH-DPAT is not antagonized by the 5-HT 1A -receptor antagonist WAY100635, thus indicating that the presynaptic inhibition of glutamate release from both Aδ and C primary afferents are not mediated by the activation of the 5-HT 1A -receptor subtypes. The enhancement of the transmitter release from the primary afferents has also been reported (74) . The enhancement of mEPSCs in frequency might thus be due to either the activation of glutamate release from interneurons or primary afferent fibers. However, the receptor responsible for such action has not yet been clarified (Fig. 3) .
Plastic changes of the serotonergic system
The descending serotonergic system seems to be plastically altered under pathological conditions. Calcitonin, a polypeptide hormone secreted from the parafollicular C cells of the mammalian thyroid gland, is widely used clinically to alleviate pain in osteoporotic patients. In the clinical treatment of pain, repeated injections of calcitonin to the periphery are required for at least 3 to 4 weeks. Although almost all previous studies have only examined the acute anti-nociceptive effects of calcitonin, Ito et al. (74) recently clarified the underlying antinociceptive mechanisms of calcitonin using ovariectomized (OVX) rats, which are known to be a model for osteoporosis. The stimulation of the dorsal root of spinal cord slices elicits monosynaptic Aδ and / or C afferent-evoked EPSC in more than 50% of the SG neurons. In sham-operated rats, bath-applied 5-HT presynaptically reduces the amplitude of both Aδ and C afferent EPSCs. On the other hand, in the OVX rats, 5-HT reduces only the Aδ afferent-evoked EPSCs without affecting the amplitude of the C afferent EPSCs. These observations indicate that 5-HT binds to the presynaptic receptors that are expressed at the Aδ and C afferent terminals under normal conditions to decrease glutamate release, resulting in a decrease in the nociceptive sensory inputs to the SG. In contrast, 5-HT only depresses the Aδ afferent evoked EPSCs in OVX rat models, and no such depression is observed in the C afferent-evoked EPSCs. Interestingly, the administration of calcitonin for more than 3 weeks to OVX rats restores the 5-HT effect on the C afferent-evoked EPSCs. 5-HT reduces both Aδ and C afferent-mediated EPSCs, presumably by the re-expression of 5-HT receptors at the C afferent terminals. The mechanisms for the reexpression of 5-HT receptor by treatment of OVX rats with calcitonin have not yet been clarified. Intriguingly, the inhibition of C-fiber but not Aδ-fiber evoked EPSCs by 5-HT is mimicked by 8-OH-DPAT, and such 8-OH-DPAT induced inhibition is not blocked by the 5-HT 1A -receptor antagonist WAY10035, thus indicating that the 8-OH-DPAT action is mediated by a 5-HT-receptor subtype that differs from 5-HT 1A . These results show that the spinal cord membranes may be endowed not only with 5-HT 1A receptors but also with 5-HT 1A -like receptors that bind to 8-OH-DPAT in a manner insensitive to WAY100635. These observations suggest that the serotonergic receptor expressed at the C afferent terminals is reduced or eliminated by ovariectomy. As a result, the excessive nociceptive inputs by the C afferents are carried to the spinal dorsal horn, thereby producing hyperalgesia.
C. Discussion: the functional significance of the noradrenergic and serotonergic systems on sensory transmission
As described above, both NA and serotonin have similar effects on the synaptic transmission in the spinal dorsal horn, in particular in SG. Other lamiae neurons have not yet been extensively examined at the single cell level. The questions that remain regarding differences between NA and serotonin are significant in terms of nociceptive transmission in the spinal dorsal horn. Both noradrenaline and serotonin produce membrane hyperpolarization, while decreasing the excitatory transmitter release from primary Aδ and C afferent fibers presynaptically and increasing the inhibitory transmitter release, including both GABA and glycine, from the interneurons. The overall effects of both descending inhibitory systems are therefore analogous. There are, however, some quantitative differences: 1) The administration of 5-HT produces membrane hyperpolarization in about 50% of SG neurons, while NA hyperpolarizes more than 80% of SG neurons, although both hyperpolarizations show no significant desensitization. Considering that SG neurons are heterogeneous according to their morphology and containing excitatory or inhibitory transmitters, the quantitative difference in the number of neurons hyperpolarized by both transmitters seems to depend on their specificity in antinociception on various modalities. NA is presumed to control the nociceptive inputs in a more general manner, while 5-HT controls the nociceptive inputs more specifically. This assumption should be better clarified, maybe utilizing an in vivo patch-clamp recording. 2) There is a significant difference between their inhibitory presynaptic actions on glutamate release. 5-HT depresses both Aδ and C afferent-evoked EPSCs without any significant difference in the ratio between the Aδ and C afferent-evoked EPSCs. In contrast, Aδ afferent evoked EPSCs are more sensitive than C afferent EPSCs to NA. As mentioned above, Aδ afferents convey preferentially the first and confined pain to the spinal cord. Therefore, NA might control acute pain rather than chronic and diffuse pain. 3) No significant difference has been observed in the inhibitory transmitter release. Both GABA and glycine are released. Although identifying the precise functional difference between NA and 5-HT must await further clarification, it should be considered that both systems not only descend to the spinal cord but also ascend to the higher sensory circuitry, including cortex; thus the overall effect of those systems should be more complicated than expected. In addition to the spinal cord level, the inputs to the 5-HT and NA nuclei should be considered. It is quite conceivable that both systems are activated by distinct situations, such as in the cases of the runner's high and wounded soldiers. Therefore, the relatively small quantitative differences observed in the action of NA and 5-HT systems on the nociceptive transmission in the spinal dorsal horn could have functionally remarkable significance.
D. Summary
Electrophysiological studies have disclosed the antinociceptive mechanisms of descending NA and 5-HT systems at least at the spinal cord level. Both systems 1) directly hyperpolarize SG neurons, 2) inhibit the glutamate release from the Aδ and C afferent fibers, and 3) increase GABA and glycine release from interneurons. Although some excitatory effects have been reported, the overall effect of both systems tends to be anti-nociceptive. These systems might therefore play an important role in determining how humans behave in critical situations by temporarily ignoring pain, or as described by a Scottish explorer, David Livingston, this temporal ignorance of pain is a merciful provision by our benevolent creator to lessen the pain of death (Missionary Travels, 1857).
